国际免疫学杂志
國際免疫學雜誌
국제면역학잡지
INTERNATIONAL JOURNAL OF IMMUNOLOGY
2013年
2期
142-148
,共7页
吕庆杰%刘剑勇%赵荫农%刘春辉%张志明%冯钟煦%崔英%梁新强%唐凯
呂慶傑%劉劍勇%趙蔭農%劉春輝%張誌明%馮鐘煦%崔英%樑新彊%唐凱
려경걸%류검용%조음농%류춘휘%장지명%풍종후%최영%량신강%당개
GPC3%重组质粒%pEGFP-GPC3%树突状细胞
GPC3%重組質粒%pEGFP-GPC3%樹突狀細胞
GPC3%중조질립%pEGFP-GPC3%수돌상세포
GPC3%Recombinant plasmid%pEGFP-GPC3%Dendritic cells
目的 探讨pEGFP-GPC3转染小鼠骨髓来源树突状细胞(DC)是否能诱导小鼠产生特异性抗肝癌免疫以达到抗肝癌目的.方法 建立荷瘤小鼠模型,随机分A、B、C三组,分别予腹腔注射pEGFP-GPC3转染的DC、pEGFP-N1转染的DC及生理盐水,提取各组小鼠脾淋巴细胞(脾LC)检测细胞毒性T淋巴细胞(CTL)活性,观察瘤体内淋巴细胞浸润及肿瘤细胞坏死情况并计算抑瘤率.结果 A组小鼠脾LC对小鼠H22肝癌细胞(H22细胞)的杀伤率相比差异明显高于其对小鼠C127乳腺癌细胞(C127细胞)的杀伤率(t=17.365,P<0.01);B组小鼠脾LC对H22细胞及C127细胞的杀伤率无统计学意义(t=0.654,P>0.05);C组小鼠脾LC对H22细胞及C127细胞的杀伤率无统计学意义(t=1.291,P>0.05);A、B、C组对H22细胞杀伤率分别比较,A>B>C(F=587.658,P<0.01).A组瘤体石蜡病理切片淋巴细胞浸润情况明显高于B组和C组(x2=1.075,P<0.01).以C组为对照组,A、B组抑瘤率比较:A组>B组.结论 重组质粒pEGFP-GPC3转染的DC能显著提高小鼠机体对H22肝癌细胞的特异性免疫.
目的 探討pEGFP-GPC3轉染小鼠骨髓來源樹突狀細胞(DC)是否能誘導小鼠產生特異性抗肝癌免疫以達到抗肝癌目的.方法 建立荷瘤小鼠模型,隨機分A、B、C三組,分彆予腹腔註射pEGFP-GPC3轉染的DC、pEGFP-N1轉染的DC及生理鹽水,提取各組小鼠脾淋巴細胞(脾LC)檢測細胞毒性T淋巴細胞(CTL)活性,觀察瘤體內淋巴細胞浸潤及腫瘤細胞壞死情況併計算抑瘤率.結果 A組小鼠脾LC對小鼠H22肝癌細胞(H22細胞)的殺傷率相比差異明顯高于其對小鼠C127乳腺癌細胞(C127細胞)的殺傷率(t=17.365,P<0.01);B組小鼠脾LC對H22細胞及C127細胞的殺傷率無統計學意義(t=0.654,P>0.05);C組小鼠脾LC對H22細胞及C127細胞的殺傷率無統計學意義(t=1.291,P>0.05);A、B、C組對H22細胞殺傷率分彆比較,A>B>C(F=587.658,P<0.01).A組瘤體石蠟病理切片淋巴細胞浸潤情況明顯高于B組和C組(x2=1.075,P<0.01).以C組為對照組,A、B組抑瘤率比較:A組>B組.結論 重組質粒pEGFP-GPC3轉染的DC能顯著提高小鼠機體對H22肝癌細胞的特異性免疫.
목적 탐토pEGFP-GPC3전염소서골수래원수돌상세포(DC)시부능유도소서산생특이성항간암면역이체도항간암목적.방법 건립하류소서모형,수궤분A、B、C삼조,분별여복강주사pEGFP-GPC3전염적DC、pEGFP-N1전염적DC급생리염수,제취각조소서비림파세포(비LC)검측세포독성T림파세포(CTL)활성,관찰류체내림파세포침윤급종류세포배사정황병계산억류솔.결과 A조소서비LC대소서H22간암세포(H22세포)적살상솔상비차이명현고우기대소서C127유선암세포(C127세포)적살상솔(t=17.365,P<0.01);B조소서비LC대H22세포급C127세포적살상솔무통계학의의(t=0.654,P>0.05);C조소서비LC대H22세포급C127세포적살상솔무통계학의의(t=1.291,P>0.05);A、B、C조대H22세포살상솔분별비교,A>B>C(F=587.658,P<0.01).A조류체석사병리절편림파세포침윤정황명현고우B조화C조(x2=1.075,P<0.01).이C조위대조조,A、B조억류솔비교:A조>B조.결론 중조질립pEGFP-GPC3전염적DC능현저제고소서궤체대H22간암세포적특이성면역.
Objective To investigate the machenism of mouse bone marrow-derived dendritic cells (DC) transfected with recombinant eukaryotic plasmid pEGFP-GPC3 inducing specific antitumor responses against hepatocellular carcinoma in mice.Methods Tumor-bearing mice were divided randomly into three gourps (A,B,C) for the injection of DC transfected with pEGFP-GPC3,DC transfected with pEGFP-N1 and physiological saline,respectively.CTL activities of splenic lymphocytes obtained from each group were tested.Tumor infiltrating lymphocytes and the level of tumor necrosis were further observed to assess the tumor inhibition rate.Results The cytotoxic activity of spleen lymphocytes on mice H22 hepatocellular carcinoma cells (H22 cells) was found significantly higher than that on mice C127 breast cancer cells (C127 cells) in the pEGFP-GPC3 gourp (t =17.365,P < 0.01).No statistically difference between the cytotoxic activity of spleen lymphocytes on H22 cells and on C127 cells was found in the other two groups (t =0.654,P > 0.05 ;t =1.291,P >0.05,respectively).The cytotoxic activity of spleen lymphocytes on H22 cells was highest in the pEGFP-GPC3 group,while lowest in the physiological saline group (F =587.658,P < 0.01).The tumor lymphocytes infiltration rate was the highest in the pEGFP-GPC3 gourp (x2 =1.075E,P < 0.01).while the lowest in the the physiological saline group.In additon,the tumor inhibition rate of the pEGFP-GPC3 group was higher than the pEGFP-N1 group.Conclusion DC transfected with recombinant eukaryotic plasmid pEGFPGPC3 may induce specific immune responses against H22 cells.